Options
Eukaryotic Translation Initiation Factor 3, Subunit a, Regulates the Extracellular Signal-Regulated Kinase Pathway
Alternative Title
The Translation Factor eIF3a Regulates the Extracellular Signal regulated Kinase (ERK) Pathway
Author(s)
Date Issued
2011-10-24
Date Available
2013-11-29T13:25:35Z
Abstract
The extracellular signal-regulated kinase (ERK) pathway participates in the control of numerous cellular processes, including cell proliferation. Since its activation kinetics are critical for to its biological effects, they are tightly regulated. We report that the protein translation factor, eukaryotic translation initiation factor 3, subunit a (eIF3a), binds to SHC and Raf-1, two components of the ERK pathway. The interaction of eIF3a with Raf-1 is increased by β-arrestin2 expression and transiently decreased by epidermal growth factor (EGF) stimulation in a concentration-dependent manner. The EGF-induced decrease in Raf-1–eIF3a association kinetically correlates with the time course of ERK activation. eIF3a interferes with Raf-1 activation and eIF3a downregulation by small interfering RNA enhances ERK activation, early gene expression, DNA synthesis, expression of neuronal differentiation markers in PC12 cells, and Ras-induced focus formation in NIH 3T3 cells. Thus, eIF3a is a negative modulator of ERK pathway activation and its biological effects.
Other Sponsorship
This study was supported by Medical Research Council grant G0400053/69186 and by Science Foundation Ireland under grant 06/CE/B1129.
Type of Material
Journal Article
Publisher
American Society for Microbiology
Journal
Molecular and Cellular Biology
Volume
32
Issue
1
Start Page
88
End Page
95
Copyright (Published Version)
2011 American Society for Microbiology
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
Owning collection
Scopus© citations
31
Acquisition Date
Apr 17, 2024
Apr 17, 2024
Views
1508
Last Month
3
3
Acquisition Date
Apr 17, 2024
Apr 17, 2024
Downloads
404
Last Month
6
6
Acquisition Date
Apr 17, 2024
Apr 17, 2024